ABOUND.70+: Safety and efficacy of nab-paclitaxel/carboplatin (nab-P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).
暂无分享,去创建一个
Edward S. Kim | C. Langer | J. Goldman | J. Weiss | T. Ong | R. Jotte | D. Haggstrom | C. Dakhil | A. Sanford | K. Amiri | E. Anderson | K. Konduri | Matei Socoteanu | David Smith